Scalper1 News
Kite Pharma stock was up 67% in midday trading in its IPO debut Friday, the top performer of five biotechs that launched this week. Demand was strong for the initial public offering of Kite Pharma (KITE). The stock priced at 17, above the upwardly revised range of 15 to 16. It was trading near 28.50 midday on the stock market today. Kite raised $128 million by offering 7.5 million shares, an increase from the 6 million originally planned. Based in Scalper1 News
Scalper1 News